Massimo C Mauri

Summary

Affiliation: University of Milan
Country: Italy

Publications

  1. ncbi Clozapine metabolism rate as a possible index of drug-induced granulocytopenia
    M C Mauri
    Department of Clinical Psychiatry, University of Milan, I R C C S Ospedale Maggiore di Milano, Italy
    Psychopharmacology (Berl) 137:341-4. 1998
  2. ncbi Predictors of clinical outcome in schizophrenic patients responding to clozapine
    Massimo C Mauri
    Clinical Psychiatry Department, University of Milan, IRCCS Ospedale Maggiore, Via F Sforza 35, 20122 Milan, Italy
    J Clin Psychopharmacol 23:660-4. 2003
  3. ncbi Long-term efficacy and therapeutic drug monitoring of sertraline in major depression
    Massimo C Mauri
    Clinical Psychiatry, University of Milan, Clinical Neuropsychopharmacology Unit, IRCCS, Ospedale Maggiore, Milan, Italy
    Hum Psychopharmacol 18:385-8. 2003
  4. ncbi Efficacy of clozapine in a non-schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis
    M C Mauri
    Department Clinical Psychiatry, University of Milan, IRCCS Ospedale Maggiore, Milan, Italy
    Hum Psychopharmacol 17:253-5. 2002
  5. ncbi Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels
    Massimo C Mauri
    Clinical Neuropsycshopharmacology Unit, Department of Clinical Psychiatry, University of Milan, IRCCS Ospedale Maggiore, Policlinico, Guardia II, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 26:597-601. 2002
  6. ncbi Predictive value of amino acids in the treatment of major depression with fluvoxamine
    M C Mauri
    Department of Internal Medicine, University of Milan, Clinical Neuropsychopharmacology Unit, IRCCS Ospedale Maggiore di Milano, Milan, Italy
    Neuropsychobiology 44:134-8. 2001
  7. ncbi Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels
    M C Mauri
    Department of Clinical Psychiatry, Clinical Neuropsychopharmacology Unit, University of Milan, IRCCS Ospedale Maggiore, Via F Sforza 35, 20122 Milan, Italy
    Eur Psychiatry 16:57-63. 2001
  8. ncbi Depressive symptoms and schizophrenic relapses: the effect of four neuroleptic drugs
    M C Mauri
    Department of Clinical Psychiatry, University of Milan
    Prog Neuropsychopharmacol Biol Psychiatry 23:43-54. 1999
  9. ncbi Patterns of clinical use of antipsychotics in hospitalized psychiatric patients
    Massimo C Mauri
    Clinical Psychiatry, Clinical Neuropsychopharmacology Unit, Ospedale Maggiore Policlinico IRCCS, Via Sforza 35, 20122, Milan, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 29:957-63. 2005
  10. ncbi Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs
    Massimo C Mauri
    Clinical Psychiatry, University of Milan, Clinical Neuropsychopharmacology Unit, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Via F Sforza 35, 20122 Milano, Italy
    Schizophr Res 99:7-12. 2008

Collaborators

Detail Information

Publications17

  1. ncbi Clozapine metabolism rate as a possible index of drug-induced granulocytopenia
    M C Mauri
    Department of Clinical Psychiatry, University of Milan, I R C C S Ospedale Maggiore di Milano, Italy
    Psychopharmacology (Berl) 137:341-4. 1998
    ..002, r = 0.25). These preliminary data suggest that the NCLZ/CLZ ratio, as an index of CLZ metabolism, might be a possible risk factor associated with CLZ treatment...
  2. ncbi Predictors of clinical outcome in schizophrenic patients responding to clozapine
    Massimo C Mauri
    Clinical Psychiatry Department, University of Milan, IRCCS Ospedale Maggiore, Via F Sforza 35, 20122 Milan, Italy
    J Clin Psychopharmacol 23:660-4. 2003
    ..03). Our results seem to suggest the importance of pharmacodynamic, constitutional, and genetic data over strict pharmacokinetics in determining the clinical response to CLZ...
  3. ncbi Long-term efficacy and therapeutic drug monitoring of sertraline in major depression
    Massimo C Mauri
    Clinical Psychiatry, University of Milan, Clinical Neuropsychopharmacology Unit, IRCCS, Ospedale Maggiore, Milan, Italy
    Hum Psychopharmacol 18:385-8. 2003
    ..Monitoring the SRT plasma level, even though not strictly necessary from a clinical point of view, can be useful in optimizing treatment...
  4. ncbi Efficacy of clozapine in a non-schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis
    M C Mauri
    Department Clinical Psychiatry, University of Milan, IRCCS Ospedale Maggiore, Milan, Italy
    Hum Psychopharmacol 17:253-5. 2002
    ..The authors report the first case of a non-schizophrenic patient affected by polydipsia and central pontine myelinolysis who was successfully treated with clozapine...
  5. ncbi Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels
    Massimo C Mauri
    Clinical Neuropsycshopharmacology Unit, Department of Clinical Psychiatry, University of Milan, IRCCS Ospedale Maggiore, Policlinico, Guardia II, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 26:597-601. 2002
    ..Drug plasma level determination does not seem be strictly necessary from a clinical point of view but further research seems advisable in patients at risk like elderly and during long-term studies...
  6. ncbi Predictive value of amino acids in the treatment of major depression with fluvoxamine
    M C Mauri
    Department of Internal Medicine, University of Milan, Clinical Neuropsychopharmacology Unit, IRCCS Ospedale Maggiore di Milano, Milan, Italy
    Neuropsychobiology 44:134-8. 2001
    ..Patients showed significantly higher tyrosine/large neutral amino acids (LNAAs) and lower tryptophan/LNAAs, ratios which could represent an index of good response to a serotonergic drug like FVX...
  7. ncbi Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels
    M C Mauri
    Department of Clinical Psychiatry, Clinical Neuropsychopharmacology Unit, University of Milan, IRCCS Ospedale Maggiore, Via F Sforza 35, 20122 Milan, Italy
    Eur Psychiatry 16:57-63. 2001
    ..RSP seems to be quite an effective drug. It seems, however, difficult to devise appropriate dose schedules and plasma level determination seems to be necessary in some cases...
  8. ncbi Depressive symptoms and schizophrenic relapses: the effect of four neuroleptic drugs
    M C Mauri
    Department of Clinical Psychiatry, University of Milan
    Prog Neuropsychopharmacol Biol Psychiatry 23:43-54. 1999
    ..6. L-sulpiride showed a trend to be most effective on depressive symptomatology in comparison to the other neuroleptics...
  9. ncbi Patterns of clinical use of antipsychotics in hospitalized psychiatric patients
    Massimo C Mauri
    Clinical Psychiatry, Clinical Neuropsychopharmacology Unit, Ospedale Maggiore Policlinico IRCCS, Via Sforza 35, 20122, Milan, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 29:957-63. 2005
    ..The results of this study confirm the trend to use combinations of one typical and one atypical antipsychotic, and higher doses...
  10. ncbi Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs
    Massimo C Mauri
    Clinical Psychiatry, University of Milan, Clinical Neuropsychopharmacology Unit, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Via F Sforza 35, 20122 Milano, Italy
    Schizophr Res 99:7-12. 2008
    ....
  11. ncbi Hallucinatory disorder, an original clinical picture? Clinical and imaging data
    Massimo C Mauri
    Clinical Psychiatry, Clinical Neuropsycopharmacology Unit, Fondazione IRCCS, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 32:523-30. 2008
    ....
  12. ncbi Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response
    Massimo C Mauri
    Department of Internal Medicine, Clinical Psychiatry, University of Milan, IRCCS Ospedale Maggiore Policlinico, Milan, Italy
    Clin Pharmacokinet 46:359-88. 2007
    ..A therapeutic range of 100-400 ng/mL is proposed from non-systematic clinical experience. There is no direct evidence concerning optimal plasma concentration ranges of ziprasidone, aripiprazole or sertindole...
  13. ncbi Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels
    Massimo C Mauri
    University of Milan, Clinical Psychiatry Department, Clinical Neuropsychopharmacology Unit, Fondazione IRCCS Ospedale Maggiore, Milan, Italy
    Expert Opin Pharmacother 8:2207-13. 2007
    ..To evaluate clinical outcomes and the tolerability of 2 weeks' quetiapine (QTP) treatment for hospitalised patients in a naturalistic setting...
  14. ncbi Hallucinatory disorder: preliminary data for a clinical diagnostic proposal
    Massimo C Mauri
    University of Milan Medical School, IRCCS Ospedale Maggiore di Milano, Milano, Italy
    Cogn Neuropsychiatry 11:480-92. 2006
    ..We compared a group of patients with a clinical picture related to this syndrome to a group of patients with schizophrenia in order to evaluate the possibility of characterising hallucinatory disorder as a diagnostic entity...
  15. ncbi Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study
    A Carlo Altamura
    Department of Clinical Psychiatry, University of Milan, IRCCS Foundation Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
    Clin Drug Investig 32:213-9. 2012
    ..The mechanism of this activity is unknown although it may be mediated by its metabolite N-desalkylquetiapine (norquetiapine)...
  16. ncbi Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up
    Giovanni M Ruggiero
    Studi Cognitivi Research Center and Psychotherapy School, Milan, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 27:425-30. 2003
    ..On the other hand, fear of fatness and the scores of the subscales of the EDI significantly decreased in the nutritional treatment group. In terms of weight, the pharmacological group presented the higher amount of therapeutic success...
  17. ncbi Neuropsychological functions and metabolic aspects in subclinical hypothyroidism: the effects of L-thyroxine
    Marina Baldini
    U O Medicina Interna 1 A, Padiglione Granelli, IRCCS Fondazione Policlinico, MA, R E, Via Francesco Sforza 35, 20122, Milan, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 33:854-9. 2009
    ....